Recall Notice Regarding Amca Yumin Solution
2022-11-17
Our company’s Amca Yumin Solution (Batch Numbers: 20220302, 20220501) may have quality issues related to abnormal fill volumes. To eliminate any risks to patients, the company is voluntarily recalling the two batches mentioned above (20220302 and 20220501) of Amca Yumin Solution.
To all pharmaceutical distribution enterprises and user units:
Our company’s Amca Yumin Solution (Batch Numbers: 20220302, 20220501) may have quality issues related to abnormal fill volumes. To eliminate any risks to patients, the company is voluntarily recalling the two batches mentioned above (20220302 and 20220501) of Amca Yumin Solution. Given the medication safety risks associated with these two batches, in accordance with the relevant provisions of the “Measures for Drug Recall Management,” this recall will be managed as a Class III recall.
The following information pertains to the ammonium caffeine antihistamine solution that requires a recall:
|
Batch number |
Packaging specifications |
Recall quantity |
|
20220302 |
100 ml/bottle/box × 1 2 0 boxes/pieces |
14,780 boxes |
|
20220501 |
150 ml/bottle/box × 6 0 box /per item |
8,540 boxes |
Upon receipt of this notice, please immediately cease the sale and use of the Amca Yumin Solution batches with the above-mentioned batch numbers, and assist our company in conducting a recall and collection effort in the end-market based on their sales distribution. For any business-related issues during the return process, please contact our Company’s Sales Service Department; for quality-related issues, please contact our Company’s Quality Department.
Our company sincerely apologizes for any inconvenience caused to our customers!
Contact Information:
Quality Department: Liu Gaijing, Phone: 0851-84832198 18708676149
Sales and Service Department: Yang Hui, Phone: 0851-84832198 13809482427
Return address for products: Building B, Jinghong Industrial Park, No. 338 Baiyun North Road, Baiyun District, Guiyang City, Guizhou Province
Guizhou Finder Pharmaceutical Co.Ltd.
November 16, 2022
Relevant documents
Related News